» Articles » PMID: 23796937

Polymyxin B Induces Apoptosis in Kidney Proximal Tubular Cells

Overview
Specialty Pharmacology
Date 2013 Jun 26
PMID 23796937
Citations 49
Authors
Affiliations
Soon will be listed here.
Abstract

The nephrotoxicity of polymyxins is a major dose-limiting factor for treatment of infections caused by multidrug-resistant Gram-negative pathogens. The mechanism(s) of polymyxin-induced nephrotoxicity is not clear. This study aimed to investigate polymyxin B-induced apoptosis in kidney proximal tubular cells. Polymyxin B-induced apoptosis in NRK-52E cells was examined by caspase activation, DNA breakage, and translocation of membrane phosphatidylserine using Red-VAD-FMK [Val-Ala-Asp(O-Me) fluoromethyl ketone] staining, a terminal deoxynucleotidyltransferase-mediated dUTP-biotin nick end labeling (TUNEL) assay, and double staining with annexin V-propidium iodide (PI). The concentration dependence (50% effective concentration [EC]) and time course for polymyxin B-induced apoptosis were measured in NRK-52E and HK-2 cells by fluorescence-activated cell sorting (FACS) with annexin V and PI. Polymyxin B-induced apoptosis in NRK-52E cells was confirmed by positive labeling from Red-VAD-FMK staining, TUNEL assay, and annexin V-PI double staining. The EC (95% confidence interval [CI]) of polymyxin B for the NRK-52E cells was 1.05 (0.91 to 1.22) mM and was 0.35 (0.29 to 0.42) mM for HK-2 cells. At lower concentrations of polymyxin B, minimal apoptosis was observed, followed by a sharp rise in the apoptotic index at higher concentrations in both cell lines. After treatment of NRK-52E cells with 2.0 mM polymyxin B, the percentage of apoptotic cells (mean ± standard deviation [SD]) was 10.9% ± 4.69% at 6 h and reached plateau (>80%) at 24 h, whereas treatment with 0.5 mM polymyxin B for 24 h led to 93.6% ± 5.57% of HK-2 cells in apoptosis. Understanding the mechanism of polymyxin B-induced apoptosis will provide important information for discovering less nephrotoxic polymyxin-like lipopeptides.

Citing Articles

The structure of lipopeptides impacts their antiviral activity and mode of action against SARS-CoV-2 .

Hoste A, Smeralda W, Cugnet A, Brostaux Y, Deleu M, Garigliany M Appl Environ Microbiol. 2024; 90(11):e0103624.

PMID: 39445780 PMC: 11577759. DOI: 10.1128/aem.01036-24.


Evaluating nephrotoxicity reduction in a novel polymyxin B formulation: insights from a 3D kidney-on-a-chip model.

Payasi A, Yadav M, Chaudhary S, Aggarwal A Antimicrob Agents Chemother. 2024; 68(10):e0021924.

PMID: 39225483 PMC: 11459911. DOI: 10.1128/aac.00219-24.


Cyclization increases bactericidal activity of arginine-rich cationic cell-penetrating peptide for .

John C, Otala S, Jarvis G Microbiol Spectr. 2024; 12(9):e0099724.

PMID: 39105587 PMC: 11370255. DOI: 10.1128/spectrum.00997-24.


Comparison of the Impact of VRP-034 and Polymyxin B upon Markers of Kidney Injury in Human Proximal Tubule Monolayers In Vitro.

Pye K, Tasinato E, Shuttleworth S, Devlin C, Brown C Antibiotics (Basel). 2024; 13(6).

PMID: 38927196 PMC: 11201133. DOI: 10.3390/antibiotics13060530.


Antimicrobial Peptides towards Clinical Application-A Long History to Be Concluded.

Cresti L, Cappello G, Pini A Int J Mol Sci. 2024; 25(9).

PMID: 38732089 PMC: 11084544. DOI: 10.3390/ijms25094870.


References
1.
Randall R, Bridi G, SETTER J, Brackett N . Recovery from colistimethate nephrotoxicity. Ann Intern Med. 1970; 73(3):491-2. DOI: 10.7326/0003-4819-73-3-491. View

2.
Falagas M, Kasiakou S . Toxicity of polymyxins: a systematic review of the evidence from old and recent studies. Crit Care. 2006; 10(1):R27. PMC: 1550802. DOI: 10.1186/cc3995. View

3.
Samali A, Zhivotovsky B, Jones D, Nagata S, Orrenius S . Apoptosis: cell death defined by caspase activation. Cell Death Differ. 1999; 6(6):495-6. DOI: 10.1038/sj.cdd.4400520. View

4.
Price D, Graham D . Effects of large doses of colistin sulphomethate sodium on renal function. Br Med J. 1970; 4(5734):525-7. PMC: 1820005. DOI: 10.1136/bmj.4.5734.525. View

5.
Wallace S, Li J, Nation R, Rayner C, Taylor D, Middleton D . Subacute toxicity of colistin methanesulfonate in rats: comparison of various intravenous dosage regimens. Antimicrob Agents Chemother. 2008; 52(3):1159-61. PMC: 2258545. DOI: 10.1128/AAC.01101-07. View